These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38523329)
1. Prevalence of MTHFR Polymorphisms in Patients With Hypermobile Ehlers-Danlos Syndrome and Hypermobile Spectrum Disorders in a US Hypermobility Clinic. Courseault J; Umar M; Bordnick P; Simons J; Volic M; Stock A; Bix G ACR Open Rheumatol; 2024 Jul; 6(7):399-402. PubMed ID: 38523329 [TBL] [Abstract][Full Text] [Related]
2. High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities. Fairweather D; Bruno KA; Darakjian AA; Bruce BK; Gehin JM; Kotha A; Jain A; Peng Z; Hodge DO; Rozen TD; Munipalli B; Rivera FA; Malavet PA; Knight DRT Front Med (Lausanne); 2023; 10():1096180. PubMed ID: 37181352 [TBL] [Abstract][Full Text] [Related]
3. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders. Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175 [TBL] [Abstract][Full Text] [Related]
4. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States. Estrella E; Frazier PA Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of ADHD and Autism Spectrum Disorder in Children with Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome: A Retrospective Study. Kindgren E; Quiñones Perez A; Knez R Neuropsychiatr Dis Treat; 2021; 17():379-388. PubMed ID: 33603376 [TBL] [Abstract][Full Text] [Related]
6. Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Chuchin JD; Ornstein TJ Disabil Rehabil; 2024 Sep; 46(18):4234-4245. PubMed ID: 37843031 [TBL] [Abstract][Full Text] [Related]
7. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory. Bennett SE; Walsh N; Moss T; Palmer S Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520 [TBL] [Abstract][Full Text] [Related]
8. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder. Brock I; Prendergast W; Maitland A Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):473-481. PubMed ID: 34747107 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey. Teran-Wodzinski P; Kumar A Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685 [TBL] [Abstract][Full Text] [Related]
11. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923 [TBL] [Abstract][Full Text] [Related]
12. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder. Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648 [TBL] [Abstract][Full Text] [Related]
13. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome. Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633 [TBL] [Abstract][Full Text] [Related]
14. Interactions between genetic variants involved in the folate metabolic pathway and serum lipid, homocysteine levels on the risk of recurrent spontaneous abortion. Lin Z; Li Q; Sun Y; Huang J; Wang W; Fu J; Xu J; Zeng D Lipids Health Dis; 2019 Jun; 18(1):143. PubMed ID: 31200713 [TBL] [Abstract][Full Text] [Related]
15. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center. Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134 [TBL] [Abstract][Full Text] [Related]
16. Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review. Garreth Brittain M; Flanagan S; Foreman L; Teran-Wodzinski P Disabil Rehabil; 2024 May; 46(10):1936-1953. PubMed ID: 37231592 [TBL] [Abstract][Full Text] [Related]
17. The Impact of Hypermobile "Ehlers-Danlos Syndrome" and Hypermobile Spectrum Disorder on Interpersonal Interactions and Relationships. De Baets S; De Temmerman M; Calders P; Malfait F; Van Hove G; Vanderstraeten G; De Wandele I; Van de Velde D Front Rehabil Sci; 2022; 3():832806. PubMed ID: 36188999 [TBL] [Abstract][Full Text] [Related]
18. An online pain management program for people with hypermobile Ehlers-Danlos Syndrome or hypermobility spectrum disorder: a three-staged development process. Chew MT; Ilhan E; Nicholson LL; Kobayashi S; Chan C Disabil Rehabil; 2024 May; ():1-11. PubMed ID: 38738812 [TBL] [Abstract][Full Text] [Related]
19. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome. DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116 [TBL] [Abstract][Full Text] [Related]